Author: Prates, Erica T.; Garvin, Michael R.; Pavicic, Mirko; Jones, Piet; Shah, Manesh; Alvarez, Christiane; Kainer, David; Demerdash, Omar; Amos, B Kirtley; Geiger, Armin; Pestian, John; Jin, Kang; Mitelpunkt, Alexis; Bardes, Eric; Aronow, Bruce; Jacobson, Daniel
Title: Functional Immune Deficiency Syndrome via Intestinal Infection in COVID-19 Cord-id: tug2t7dm Document date: 2020_4_11
ID: tug2t7dm
Snippet: Using a Systems Biology approach, we integrated genomic, transcriptomic, proteomic, and molecular structure information to provide a holistic understanding of the COVID-19 pandemic. The expression data analysis of the Renin Angiotensin System indicates mild nasal, oral or throat infections are likely and that the gastrointestinal tissues are a common primary target of SARS-CoV-2. Extreme symptoms in the lower respiratory system likely result from a secondary-infection possibly by a comorbidity-d
Document: Using a Systems Biology approach, we integrated genomic, transcriptomic, proteomic, and molecular structure information to provide a holistic understanding of the COVID-19 pandemic. The expression data analysis of the Renin Angiotensin System indicates mild nasal, oral or throat infections are likely and that the gastrointestinal tissues are a common primary target of SARS-CoV-2. Extreme symptoms in the lower respiratory system likely result from a secondary-infection possibly by a comorbidity-driven upregulation of ACE2 in the lung. The remarkable differences in expression of other RAS elements, the elimination of macrophages and the activation of cytokines in COVID-19 bronchoalveolar samples suggest that a functional immune deficiency is a critical outcome of COVID-19. We posit that using a non-respiratory system as a major pathway of infection is likely determining the unprecedented global spread of this coronavirus. One Sentence Summary A Systems Approach Indicates Non-respiratory Pathways of Infection as Key for the COVID-19 Pandemic
Search related documents:
Co phrase search for related documents- accessory protein and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48
- accessory protein and additional protein: 1, 2
- accessory protein and lung damage: 1
- accessory protein and lung endothelial: 1
- accessory protein and lung endothelial cell: 1
- accessory protein and lung infection: 1
- accessory protein and lung tissue: 1, 2
Co phrase search for related documents, hyperlinks ordered by date